HF
GRTS

HRT Financial’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

HRT Financial’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,610
Closed -$18K – 3337
2024
Q2 		$18K Buy
+30,610
New +$25.9K ﹤0.01% 1948
2023
Q2 		– Sell
-285,377
Closed -$793K – 3482
2023
Q1 		$793K Buy
+285,377
New +$815K 0.01% 1067
2022
Q3 		– Sell
-46,251
Closed -$111K – 3666
2022
Q2 		$111K Sell
46,251
-224,508
-83% -$590K ﹤0.01% 2413
2022
Q1 		$1.11M Buy
+270,759
New +$1.43M 0.01% 946
2021
Q1 		– Sell
-24,685
Closed -$97K – 3264
2020
Q4 		$97K Buy
+24,685
New +$74.7K ﹤0.01% 1637

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

HRT Financial's GRTS Position: Q3 2024 in Review

HRT Financial sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 30,610 shares — an estimated $18K sold.

HRT Financial first reported a position in GRTS in Q4 2020 and held it in 5 quarters. The position peaked at $1.11M in Q1 2022. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • HRT Financial reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 30,610 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $18K.
  • HRT Financial first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • HRT Financial's Gritstone bio, Inc. Common Stock position peaked at $1.11M in Q1 2022.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.